Free Androgen Index (FAI) Test at Chughtai Lab

Free Androgen Index (FAI) at Chughtai Lab

The Free Androgen Index (FAI) is a highly specialized biochemical calculation used to evaluate the status of physiologically active testosterone in the human body. Unlike total testosterone, which measures both bound and unbound hormone fractions, the FAI provides a highly accurate estimation of the “free” or biologically active testosterone circulating in the bloodstream. This index is calculated as a ratio of total testosterone to Sex Hormone-Binding Globulin (SHBG). At Chughtai Lab, a premier diagnostic institution in Pakistan, this test is performed using state-of-the-art automated immunoassay platforms to ensure the highest levels of clinical precision and diagnostic reliability.

To understand the clinical value of the Free Androgen Index, it is essential to understand how androgens circulate in the human body. Testosterone, the primary male sex hormone (androgen) present in both men and women, does not travel freely through the bloodstream. Approximately 60% to 70% of circulating testosterone is tightly bound to Sex Hormone-Binding Globulin (SHBG), a glycoprotein produced by the liver. Another 30% to 40% is weakly bound to albumin. Only a tiny fraction, typically 1% to 3%, remains completely unbound or “free.” The free and albumin-bound fractions together constitute the “bioavailable” testosterone, which is capable of entering target tissues and exerting biological effects. Because direct measurement of free testosterone via equilibrium dialysis is technically complex, expensive, and not widely available, the Free Androgen Index serves as an internationally recognized, highly reliable surrogate marker for assessing hyperandrogenism and androgen deficiency.

Chughtai Lab utilizes advanced chemiluminescent microparticle immunoassay (CMIA) or electrochemiluminescence immunoassay (ECLIA) technologies to measure both Total Testosterone and SHBG levels from a single blood sample. The laboratory’s automated systems then calculate the FAI using the standardized formula: FAI = [Total Testosterone (nmol/L) / SHBG (nmol/L)] x 100. This mathematical ratio is particularly valuable because it accounts for variations in SHBG levels, which can be significantly influenced by factors such as obesity, thyroid disorders, insulin resistance, oral contraceptive use, and liver disease. By providing a clear picture of active androgen levels, the FAI test at Chughtai Lab assists endocrinologists, gynecologists, urologists, and internal medicine specialists in diagnosing complex reproductive and metabolic disorders.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical to obtaining accurate and reproducible Free Androgen Index results, as hormone levels are highly sensitive to diurnal variations, dietary factors, and medications. Patients undergoing the FAI test at Chughtai Lab should adhere to the following preparation guidelines:

• Morning Collection: Blood samples should ideally be collected in the early morning, between 7:00 AM and 10:00 AM. Testosterone levels exhibit a diurnal rhythm, peaking in the early morning hours and declining throughout the day.
• Fasting Requirements: While fasting is not strictly mandatory for testosterone testing, a light fast of 8 to 12 hours is highly recommended. Consuming a heavy or high-fat meal immediately before the test can temporarily suppress testosterone levels, leading to inaccurate results.
• Medication Disclosure: Patients must inform their healthcare provider and the Chughtai Lab staff of all medications, supplements, and hormones they are currently taking. Specifically, oral contraceptives, hormone replacement therapy (HRT), glucocorticoids, anticonvulsants, and anabolic steroids can profoundly alter SHBG and testosterone levels.
• Biotin Supplementation: High doses of biotin (Vitamin B7), commonly found in hair, skin, and nail supplements, can interfere with the streptavidin-biotin technology used in modern immunoassays, leading to falsely elevated or depressed results. Patients should discontinue biotin supplements at least 72 hours prior to sample collection.
• Timing for Female Patients: For menstruating women, the test is typically scheduled during the early follicular phase of the menstrual cycle (usually days 2 to 5) unless otherwise directed by their physician, as hormone levels fluctuate naturally throughout the cycle.

During the Procedure

The Free Androgen Index test requires a standard venipuncture procedure, which is conducted by highly trained phlebotomists at Chughtai Lab collection centers or through their convenient home sample collection service. The procedure involves the following steps:

• Patient Identification and Verification: The phlebotomist will verify the patient’s identity, confirm compliance with preparation guidelines (such as morning timing and fasting), and explain the procedure.
• Site Selection and Cleansing: The patient is seated comfortably. The phlebotomist identifies a suitable vein, typically in the antecubital fossa (the crook of the elbow), and cleanses the skin thoroughly with an antiseptic swab (70% isopropyl alcohol) to prevent contamination.
• Venipuncture: A sterile, single-use needle is gently inserted into the vein. A vacuum collection tube (typically a gold-top serum separator tube or a red-top clot activator tube) is attached to collect the required volume of blood (approximately 3 to 5 mL).
• Post-Collection Care: Once the sample is collected, the needle is withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to prevent hematoma formation. A small adhesive bandage is applied.
• Sample Processing: The blood sample is allowed to clot, centrifuged to separate the serum, and transported under strict temperature-controlled conditions to the central testing facility of Chughtai Lab for immediate analysis.

When is a Free Androgen Index (FAI) Performed?

Evaluating Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. It is characterized by ovulatory dysfunction, polycystic ovarian morphology, and clinical or biochemical hyperandrogenism. The Free Androgen Index is considered a highly sensitive marker for detecting biochemical hyperandrogenism in women suspected of having PCOS. In many women with PCOS, total testosterone levels may fall within the normal reference range, but because insulin resistance suppresses hepatic production of SHBG, the level of free, active testosterone is significantly elevated. Measuring the FAI helps clinicians confirm a PCOS diagnosis in accordance with the Rotterdam Criteria, allowing for early intervention and management of metabolic and reproductive complications.

Investigating Female Hirsutism and Virilization

Hirsutism, defined as excess terminal hair growth in a male-pattern distribution (such as the face, chest, abdomen, and back) in women, is a direct clinical manifestation of androgen excess. Virilization represents a more severe state of hyperandrogenism, characterized by male-pattern baldness (alopecia), deepening of the voice, clitoromegaly, and increased muscle mass. When a female patient presents with these symptoms, physicians request a Free Androgen Index test at Chughtai Lab to determine the severity of androgen excess. This helps differentiate between benign conditions like idiopathic hirsutism and more serious underlying pathologies, such as late-onset congenital adrenal hyperplasia (CAH) or androgen-secreting tumors of the ovaries or adrenal glands.

Assessing Male Hypogonadism and Erectile Dysfunction

In male patients, a decline in androgen levels, known as hypogonadism, can lead to symptoms such as erectile dysfunction, decreased libido, chronic fatigue, loss of muscle mass, increased body fat, and mood disturbances. While total testosterone is the initial screening test for male hypogonadism, it can be misleading in men with altered SHBG levels. For instance, obesity, type 2 diabetes, and hypothyroidism decrease SHBG, while aging, hyperthyroidism, and liver disease increase SHBG. In these scenarios, evaluating the Free Androgen Index provides a much more accurate representation of the patient’s actual androgenic status, helping clinicians diagnose late-onset hypogonadism (andropause) and guide testosterone replacement therapy (TRT).

Monitoring Hormone Replacement and Anti-Androgen Therapies

The Free Androgen Index is an invaluable tool for monitoring the efficacy and safety of various hormonal interventions. For female patients undergoing anti-androgen therapy for PCOS, acne, or hirsutism (using medications like spironolactone, cyproterone acetate, or combined oral contraceptives), regular FAI testing helps track the suppression of active androgens. Conversely, for male patients receiving testosterone replacement therapy, monitoring the FAI ensures that free testosterone levels are restored to a physiological range without reaching supraphysiological levels, which could increase the risk of cardiovascular complications, erythrocytosis, or prostate issues.

Investigating Unexplained Infertility and Menstrual Irregularities

Chronic anovulation, oligomenorrhea (infrequent periods), and amenorrhea (absence of periods) are frequently linked to endocrine imbalances. Excess circulating free androgens can disrupt the delicate hypothalamic-pituitary-ovarian axis, preventing normal follicular development and ovulation, which ultimately leads to infertility. When a couple presents with unexplained infertility, or when a female patient experiences highly irregular menstrual cycles, the Free Androgen Index is included in the diagnostic workup. Identifying elevated FAI levels allows reproductive endocrinologists to design targeted treatment plans, such as ovulation induction or insulin-sensitizing therapies, to restore fertility.

What Does a Free Androgen Index (FAI) Detect?

The Free Androgen Index is a comprehensive diagnostic tool that, when interpreted alongside clinical symptoms, can detect a wide range of endocrine, metabolic, and reproductive abnormalities. Specifically, the FAI test at Chughtai Lab can detect and help evaluate:

• Biochemical hyperandrogenism in female patients presenting with acne, hirsutism, or menstrual irregularities.
• Suppressed levels of Sex Hormone-Binding Globulin (SHBG) caused by moderate-to-severe insulin resistance.
• Elevated bioavailable testosterone levels consistent with Polycystic Ovary Syndrome (PCOS).
• Mild androgen excess associated with idiopathic hirsutism.
• Severe androgen excess suggestive of rare, androgen-secreting ovarian neoplasms (e.g., Sertoli-Leydig cell tumors).
• Adrenal source of androgen excess, such as androgen-secreting adrenal adenomas or carcinomas.
• Late-onset or non-classic Congenital Adrenal Hyperplasia (CAH) in adult females.
• Hypogonadotropic hypogonadism in males, characterized by low FAI and low gonadotropin levels.
• Hypergonadotropic hypogonadism in males, indicating primary testicular failure.
• Age-related decline in bioavailable testosterone (late-onset male hypogonadism).
• Elevated SHBG levels associated with hyperthyroidism, which artificially lowers the FAI despite normal total testosterone.
• Decreased SHBG levels associated with hypothyroidism, which artificially elevates the FAI.
• Metabolic syndrome and obesity-induced alterations in sex hormone carrier proteins.
• The physiological impact of liver cirrhosis on SHBG synthesis and subsequent androgen-estrogen balance.
• Hormonal changes induced by Cushing’s syndrome or exogenous glucocorticoid therapy.
• The biochemical efficacy of combined oral contraceptive pills in raising SHBG and lowering FAI.
• Compliance and physiological response to anti-androgen medications.
• Therapeutic adequacy of testosterone replacement therapy (TRT) in hypogonadal men.
• Androgen deficiency in women presenting with unexplained low libido, fatigue, and osteopenia.
• Potential abuse of anabolic-androgenic steroids or exogenous testosterone formulations.
• Endocrine disruptions associated with hyperprolactinemia or growth hormone disorders (acromegaly).

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its commitment to providing rapid, accurate, and highly accessible diagnostic reporting. Because the Free Androgen Index requires the precise measurement of both Total Testosterone and Sex Hormone-Binding Globulin, the samples undergo automated, high-throughput immunoassay testing under strict quality control protocols. Typically, FAI test results are finalized and verified by a consultant pathologist within 12 to 24 hours of sample collection.

To enhance patient convenience, Chughtai Lab offers multiple digital avenues for accessing test reports. Once the results are verified, patients receive an automated SMS notification containing a direct link to download their report. Reports can also be accessed online through the official Chughtai Lab web portal (myreport.chughtailab.com) or via the user-friendly Chughtai Lab mobile application, which is available for both iOS and Android platforms. The digital reports feature clear reference ranges, historical data comparison (if previous tests were performed at Chughtai Lab), and a secure QR code for verification. For patients who prefer physical copies, printed reports can be collected from any of the numerous Chughtai Lab collection centers located across Pakistan.

Free Androgen Index (FAI) Findings Overview

The interpretation of the Free Androgen Index requires a detailed understanding of the normal physiological ranges, which vary significantly based on biological sex, age, and menstrual status. The table below outlines the typical parameters evaluated during an FAI test, along with normal and potential abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Total Testosterone (Female)	0.1 – 1.8 nmol/L (varies by age and lab assay)	Elevated in PCOS, ovarian/adrenal tumors, CAH; Decreased in bilateral oophorectomy, adrenal insufficiency.
Total Testosterone (Male)	8.6 – 29.0 nmol/L (varies by age and diurnal timing)	Decreased in primary/secondary hypogonadism, aging, chronic illness; Elevated in androgen-secreting tumors, steroid abuse.
Sex Hormone-Binding Globulin (SHBG) (Female)	18 – 144 nmol/L (higher during pregnancy/oral contraceptive use)	Decreased in insulin resistance, obesity, PCOS, hypothyroidism; Elevated in hyperthyroidism, pregnancy, liver disease.
Sex Hormone-Binding Globulin (SHBG) (Male)	10 – 57 nmol/L (increases naturally with age)	Decreased in obesity, metabolic syndrome, hypothyroidism, nephrotic syndrome; Elevated in aging, hyperthyroidism, cirrhosis.
Free Androgen Index (FAI) (Female)	0.5% – 6.5% (typically low in healthy females)	Elevated (> 6.5%) in PCOS, hirsutism, virilizing syndromes; Decreased in ovarian insufficiency, adrenal fatigue.
Free Androgen Index (FAI) (Male)	30% – 150% (highly dependent on age)	Decreased (< 30%) in male hypogonadism, andropause, testicular failure; Elevated in hyperandrogenic states, exogenous use.
Clinical Correlation (PCOS Profile)	Balanced LH/FSH ratio, normal insulin, normal FAI	Elevated FAI combined with insulin resistance, elevated LH/FSH ratio, and clinical hirsutism.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Free Androgen Index (FAI)?

• Experienced Healthcare Professionals: Chughtai Lab’s pathology department is led by highly qualified consultant pathologists and clinical biochemists who oversee all hormonal assays.
• State-of-the-Art Technology: The laboratory utilizes fully automated, internationally recognized immunoassay analyzers to ensure maximum precision and reproducibility of results.
• ISO 15189 Certification: Chughtai Lab adheres to stringent international quality standards, holding prestigious certifications that guarantee diagnostic accuracy.
• Convenient Home Sample Collection: Patients can schedule a professional phlebotomist to collect their blood sample from the comfort of their home or office.
• Rapid Turnaround Time: Automated processing systems enable Chughtai Lab to deliver verified FAI results within 12 to 24 hours of sample collection.
• Seamless Digital Access: Patients can easily view, download, and share their reports via the Chughtai Lab mobile app or online portal.
• Extensive Nationwide Network: With hundreds of collection centers across Pakistan, finding a Chughtai Lab facility is highly convenient for patients in any major city.
• Comprehensive Endocrine Panels: Chughtai Lab offers complete hormonal profiles, allowing patients to test FAI alongside related markers like Insulin, LH, FSH, DHEA-S, and Thyroid hormones.